Skip to content

TECO Aspergillus Galactomannan Assay 

Key Features


Detection of Aspergillus galactomannan antigen for the diagnosis of Invasive Aspergillosis (IA)


Product Description



The mortality rate of Invasive Aspergillosis is between 60 and 100% without timely treatment, thus reliable determination of galactomannan antigen may be essential.

  • Sandwich ELISA as diagnostic gold standard
  • Validated for serum and BAL samples
  • Significantly simplified sample preparation
  • Only 150 µL sample volume required
  • Limit of detection: 0.67 ng/ml (serum); 1.09 ng/ml (BAL)
  • Automation possible from sample to final result

Detection of galactomannan antigens as indicators of Aspergillus spec. infection using anti-galactomannan monoclonal antibodies and HRP-mediated color reaction. Established diagnostic procedure, significantly simplified sample preparation.


Request Quotation


Product
SKU
Pack Size
Qty
TECO Aspergillus Galactomannan Assay
SKU
TE1067
Pack Size
96 tests

Request Documentation


TECO Aspergillus Galactomannan Assay
TE1067

Associated Products



Latest News


Hepatitis D Virus: Diagnostic Complexity and Public Health Challanges in 2025

During this webinar, Frédéric LE GAL, PhD (HDR), specialist in Hepatitis Delta Virus at the National Reference Center for HDV in France, will present all these diagnostic difficulties in relation to the characteristics of the virus with a view to improving tests for wide dissemination of screening and shedding light on the global epidemiology of this virus.

Meet us at BLTG meeting!

The British Association for the Study of Liver (BASL) Annual Meeting 2025 is being held at the ICC in the heart of Belfast city during October 7th-9th. Eurobio Scientific UK will be exhibiting at the British Liver Transplant Group (BLTG) Meeting on October 7th, bringing to you the innovative PEVIVA range from VLVbio. We invite you to come along and meet us to learn more.

New Solution to Perform Specialities in Every Laboratory

Automatic multi-parameter random access system for immunoassays with ready-to-use monotest devices.

Emissions Report for January - June 2025

Contact Us